Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
featured
A Randomized, Multicenter, Double Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination with Ipilimumab, or Placebo as Maintenance Therapy in Subjects with Extensive-Stage Disease Small Cell Lung Cancer (SCLC) after Completion of Platinum-based First Line Chemotherapy

A Randomized, Multicenter, Double Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination with Ipilimumab, or Placebo as Maintenance Therapy in Subjects with Extensive-Stage Disease Small Cell Lung Cancer (SCLC) after Completion of Platinum-based First Line Chemotherapy

maintenance therapy
nivolumab
lung cancer
cancer chemotherapy
  • 432 views
  • 23 Nov, 2020
  • 1 location
featured
An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab plus Ipilimumab or Nivolumab plus Platinum Doublet Chemotherapy versus Platinum Doublet Chemotherapy in Subjects with Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab plus Ipilimumab or Nivolumab plus Platinum Doublet Chemotherapy versus Platinum Doublet Chemotherapy in Subjects with Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

platinum doublet
cancer chemotherapy
lung cancer
lung carcinoma
nivolumab
  • 182 views
  • 23 Nov, 2020
  • 1 location
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

- this study is being done to find out if the combination of carboplatin and gemcitabine will be more effective in the the treatment of advanced lung cancer if bevacizumab, an

carboplatin
advanced lung cancer
gemcitabine
bevacizumab
pleural effusion
  • 3 views
  • 07 Nov, 2020
  • 1 location
Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer

broad-spectrum value of chlorogenic acid Determine the Disease control rateDCRof phase Ib/IIa of Chlorogenic acid for injection in the advanced Lung Cancer Patients.

  • 3 views
  • 22 Jan, 2021
  • 1 location
A Study to Evaluate the Safety Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung Cancer

fully human anti-programmed cell death receptor 1 (PD-1) antibody (sintilimab) in subjects with advanced lung cancer.

  • 0 views
  • 01 Mar, 2021
  • 1 location
Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC

endothelial cells and reduce tumor microvascular density by targeting VEGFRs, FGFRs, PDGFRs. It has been proved to be safe and effective in advanced lung cancer after second-line standard chemotherapy failure

targeted therapy
measurable disease
lung carcinoma
tyrosine
gefitinib
  • 1 views
  • 23 Jan, 2021
A Study to Test Different Doses of BI 836880 Combined With BI 754091 in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

This study has 2 parts. The first part is open to adults with advanced non-small cell lung cancer. The second part is open also to adults with other types of advanced cancer of the lung

advanced cancer
solid neoplasm
neuropathy
glioblastoma multiforme
cancer treatment
  • 17 views
  • 14 Apr, 2021
  • 61 locations
Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.

primary malignant neoplasm
cancer
lung carcinoma
lung cancer
  • 206 views
  • 22 Jan, 2021
  • 19 locations
Pembrolizumab in Elderly Patients With Advanced Lung Cancer

Most tinnitus sufferers experiences significant anxiety or depression that worsens the subjective symptoms related to tinnitus. In this study, we intend to use internet-based cognitive behavioral therapy (CBT) in addition to sound therapy to provide psychotherapy to patients with tinnitus. Multiple research studies have found CBT to be effective in …

measurable disease
lung carcinoma
epidermal growth factor receptor
growth factor
mk-3475
  • 3 views
  • 23 Jan, 2021
  • 19 locations
Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib

This is a prospective, single arm, phase Ib/IIa study. Up to 25 patients will be enrolled into the study (Part A: 2-18; Part B: 7-19). The study has been designed to allow an investigation of the optimal combination dose and schedule whilst of Osimertinib plus Anlotinib in patients with EGFRm+, …

  • 0 views
  • 07 Mar, 2021
  • 1 location